Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.22 | 5e-05 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.2 | 0.0007 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.19 | 0.0007 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.18 | 0.001 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.17 | 0.005 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.008 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.14 | 0.01 |